Medigen Biotechnology Corp (3176.TWO)

3176.TWO on Gre Tai Securities Market of Chinese Taipei

155.00TWD
27 Mar 2015
Change (% chg)

NT$-0.50 (-0.32%)
Prev Close
NT$155.50
Open
NT$155.50
Day's High
NT$157.50
Day's Low
NT$154.50
Volume
590
Avg. Vol
992
52-wk High
NT$486.00
52-wk Low
NT$105.50

3176.TWO

Chart for 3176.TWO

About

MEDIGEN BIOTECHNOLOGY CORP. is engaged in the research and development of new drugs and the testing of nucleic acids. It involves in the licensing of technologies, the provision of technical services and the testing of nucleic acids. The Company's products and services include human leukocyte antigen (HLA) ABDR typing reagents,... (more)
No analyst recommendations are available for 3176.TWO.

Overall

Beta: 0.78
Market Cap(Mil.): NT$21,565.60
Shares Outstanding(Mil.): 138.69
Dividend: --
Yield (%): --

Financials

  3176.TWO Industry Sector
P/E (TTM): -- 132.14 40.89
EPS (TTM): -4.91 -- --
ROI: -24.42 -0.52 16.10
ROE: -23.70 -2.20 16.95
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks